Clinical and Laboratory Features in Anti-NF155 Autoimmune Nodopathy.
Lorena Martín-AguilarCinta LleixàElba Pascual-GoñiMarta Caballero-ÁvilaLaura Martínez-MartínezJordi Díaz-ManeraRicardo Rojas-GarcíaElena Cortés-VicenteJanina Turon-SansNoemi de LunaXavier Suárez-CalvetEduard GallardoYusuf RajaballySangeeta ScottonBart C JacobsAdája Elisabeth BaarsAndrea CorteseElisa VegezziRomana HöftbergerFritz ZimprichCornelia RoeslerEduardo Nobile-OrazioGiuseppe LiberatoreFu Liong HiewAlicia Martínez-PiñeiroAlejandra CarvajalRaquel Piñar MoralesMercedes Usón-MartínOlalla AlbertíMaria Ángeles López-PérezFabian MárquezJulio Pardo-FernándezPablo MirMacarena Cabrera-SerranoNicolau OrtizManuel BartoloméÖzgür DumanVera BrilDarwin Segura-ChávezKalliopi PitarokoiliClaudia SteenIsabel IllaLuis Antonio Querol-GutiérrezPublished in: Neurology(R) neuroimmunology & neuroinflammation (2021)
This study provides Class IV evidence that anti-NF155 antibodies associate with a specific phenotype and response to rituximab.